Medtronic STOP AF Results Show Efficacy, But Raise Some Safety Concerns
Results of Medtronic's STOP AF trial show that 69.3% of patients treated with its Arctic Front cryoballoon catheter were free from atrial fibrillation at one year
Results of Medtronic's STOP AF trial show that 69.3% of patients treated with its Arctic Front cryoballoon catheter were free from atrial fibrillation at one year